Who makes Greenplast?

Greenplast is developed by Bucheon St. Mary's Hospital.

What development phase is Greenplast in?

Greenplast is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Greenplast

Bucheon St. Mary's Hospital · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Greenplast
Also known as	Control Group
Sponsor	Bucheon St. Mary's Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Fibrin Glue After ESD for High Risk Patients of Bleeding (NA)
The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Greenplast CI brief — competitive landscape report
Greenplast updates RSS · CI watch RSS
Bucheon St. Mary's Hospital portfolio CI